This article deconstructs the IIH guidelines, contrasting medical management (acetazolamide, topiramate) with the practical ...

Neladalkib showed a 31% ORR in TKI-pretreated ALK+ NSCLC patients, with durable responses at 12 and 18 months.

Zidesamtinib targets ROS1+ NSCLC patients with prior TKI treatment, addressing CNS-penetrant treatment challenges and ...

Treatment: Cranial sacral therapy aims to improve the flow of spinal fluid, thought to be intrinsic to physical and mental well-being. Practitioners place their hands on specific parts of the body, ...

A research paper by scientists at the Capital Medical University evaluated sex differences in stroke recurrence among ...

One month of dual antithrombotic therapy followed by direct oral anticoagulation alone may be as safe vs. 1 year of dual ...

Spryte Medical, a pioneer in intravascular neuro imaging, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate the ...

A recent study published in the Journal of the American Medical Association found that the risk of a first intracranial ...

XCath, a medical device company dedicated to pioneering neuro-endovascular surgical robotics, announced today the successful first-in-human use of its EVR robotic system to treat three patients with ...

SHANGHAI, Nov. 7, 2025 /PRNewswire/ -- Cranial Technologies, a leading US medical device company specializing in the treatment of infant head shape conditions, officially introduced its flagship DOC ...

Acquisition Will Further Expand the Potential of ClearPoint Neuro's Drug Delivery Portfolio While Immediately Adding New ...

Researchers implanted electrodes in the human nucleus accumbens to track brain activity during severe food preoccupation in ...